Tofacitinib for the Treatment of Inflammatory Eye Disease
Phase of Trial: Phase II
Latest Information Update: 01 Feb 2019
At a glance
- Drugs Tofacitinib (Primary)
- Indications Scleritis; Uveitis
- Focus Therapeutic Use
- 24 Jan 2019 Planned number of patients changed from 15 to 5.
- 24 Jan 2019 Status changed from not yet recruiting to recruiting.
- 12 Jul 2018 New trial record